Brief: Annexin Pharmaceuticals Q4 Loss For Period Narrows To SEK 10.1 Mln
Feb 7 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* Q4 LOSS FOR PERIOD SEK 10.1 MILLION VERSUS LOSS SEK 15.9
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr1XhVyc
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed